At Peptidology, your safety and research integrity are our absolute priorities. We believe that true quality isn’t just claimed; it must be proven. Today, we are proud to share how we are pushing the boundaries of testing and transparency to ensure you receive the safest, most reliable research peptides available anywhere.
Pioneers in Broad Testing
We have always been innovators in safety. We take immense pride in being the very first research peptide vendor to broadly offer critical safety measures like heavy metals analysis, endotoxin testing, and true sterility verification across our entire marketplace. Innovation in peptide safety began with Peptidology, and we continue to lead the way.
Our Uncompromising Sterility Protocol (USP 71)
We do things differently because your safety demands it. Our sterility testing meticulously aligns with USP 71, the official, scientifically validated method for ensuring sterility and safety in high-quality products.
Unlike some competitors who might test a single vial, USP 71 mandates that at least 20 vials of product must be tested from every single batch. This comprehensive, multi-vial approach is the only way to properly verify the entire batch is clean, safe, and truly sterile for your critical work.
Investment in Your Research – We Prove It!
This level of comprehensive, uncompromising quality assurance requires significant resources and dedication. When we say we test, we prove it:
Transparency in Labs & Rollout
Be aware that many peptide companies use analytical laboratories that are not independently owned or do not hold accreditation by regulatory bodies. This raises serious questions about accuracy and impartiality.
At Peptidology, we proudly partner only with reputable, independent, and fully accredited analytical laboratories, ensuring unbiased, verifiable results you can trust without question.
We currently have approximately 10 of our key products undergoing this fully expanded testing protocol. We expect to implement this for all remaining products within the next 6 months, ensuring unprecedented quality assurance across our entire line.
See the Proof: Our Expanded Testing COAs
Ready to see the Peptidology difference firsthand? Click below to view detailed, fully expanded Certificates of Analysis (COAs) for three of our products, showcasing our rigorous multi-vial USP 71 sterility testing, chemical purity analysis, and more:
GLP3-R
- “Triple-agonist” targeting three different hormone receptors simultaneously: GLP-1, GIP, and glucagon.
- Researched as a highly effective treatment for obesity, type 2 diabetes, and fatty liver disease
- Currently in Phase 3 clinical trials
PNC-27
- Originally designed to bind to a specific protein (HDM2) on the membrane of cancer cells to induce cell death (necrosis).
- Potential anti-cancer properties, theoretically targeting only cancerous cells while leaving healthy cells alone
Thymosin Alpha-1
- synthetic version of a naturally occurring peptide produced by the human thymus gland, which plays a crucial role in regulating and modulating the immune system
- used to treat viral infections like Hepatitis B and C, and to act as an adjuvant to improve the body’s response to vaccines
Closing
For your critical research, don’t compromise on safety or quality. Demand the unrivaled transparency, rigorous multi-vial testing, and unwavering commitment to purity that only Peptidology provides. We remain your trusted partner in rigorous science, empowering you with absolute confidence.
